ADVNX Performance — North Square Strategic Income Fund, Class I
Data updated: 2026-09-25
ADVNX returned +1.65% year to date and +7.45% over one year to May 2026. Annualised returns are +9.52% over 3 years and +4.06% over 5 years. The fund beat its Intermediate Core Bond category average: $100 invested three years ago grew to $131, against $115 for the category, and to $107 over one year, against $105. Volatility over the past three years was 5.49% a year. In the 12 months to May 2026 the fund took in a net $782.9M, and assets reached $1.25B.
ADVNX Growth of $100
What $100 invested in North Square Strategic Income Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Intermediate Core Bond category average over the same months.
| Period | ADVNX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $107 | $105 |
| 3 years (Jun 2023 – May 2026) | $131 | $115 |
| 5 years (Jun 2021 – May 2026) | $122 | $103 |
| Since data start (Feb 2020 – May 2026) | $138 | $107 |
ADVNX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +1.65% |
| 1 year | +7.45% |
| 3 years (annualised) | +9.52% |
| 5 years (annualised) | +4.06% |
ADVNX Annual Returns
Calendar-year total returns of North Square Strategic Income Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +1.65% |
| 2025 | +11.20% |
| 2024 | +9.70% |
| 2023 | +5.10% |
| 2022 | −8.60% |
| 2021 | +5.30% |
| 2020 (Feb–Dec) | +10.17% |
ADVNX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.5% | +1.3% | −2.0% | +0.5% | +0.4% | — | — | — | — | — | — | — |
| 2025 | +1.1% | +1.2% | +0.8% | +2.4% | −0.4% | +1.2% | −1.1% | +2.4% | +1.5% | +0.4% | +1.1% | 0.0% |
| 2024 | +1.3% | −0.2% | +1.8% | −1.7% | +2.2% | +0.6% | +2.3% | +1.9% | +1.7% | −1.1% | +1.0% | −0.5% |
| 2023 | +3.4% | −2.3% | −1.3% | +0.5% | −0.9% | +0.6% | +2.2% | −0.8% | −1.8% | −2.7% | +4.4% | +4.1% |
| 2022 | −1.9% | −1.6% | −0.1% | −2.7% | −0.7% | −2.8% | +3.0% | −1.6% | −2.7% | −0.7% | +2.6% | +0.6% |
| 2021 | −0.4% | −0.1% | +0.6% | +1.6% | +1.1% | +0.3% | +0.7% | +0.3% | −0.9% | +0.8% | −0.6% | +1.8% |
| 2020 | — | −0.3% | −3.1% | +4.6% | +1.5% | +0.5% | +2.9% | +0.2% | −0.6% | −0.2% | +2.8% | +1.5% |
ADVNX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 5.49%
- 3-year Sharpe ratio: 0.91 (vs 4.5% risk-free rate)
- Best month: +4.42% (Nov 2023)
- Worst month: −2.67% (Oct 2023)
ADVNX Fund Flows
Monthly money in and out of North Square Strategic Income Fund, from SEC Form N-PORT.
- 12-month net flow: $782.9M
- 12-month gross sales (incl. reinvestments): $943.4M
- Sales ÷ redemptions: 5.88×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $49.2M | $15.6M | $33.5M |
| Apr 2026 | $97.7M | $21.0M | $76.7M |
| Mar 2026 | $124.9M | $32.1M | $92.8M |
| Feb 2026 | $151.8M | $8.0M | $143.8M |
| Jan 2026 | $116.4M | $21.4M | $95.0M |
| Dec 2025 | $92.5M | $22.4M | $70.1M |
| Nov 2025 | $53.9M | $6.7M | $47.2M |
| Oct 2025 | $82.6M | $8.1M | $74.6M |
| Sep 2025 | $39.9M | $9.7M | $30.2M |
| Aug 2025 | $47.0M | $5.1M | $41.9M |
| Jul 2025 | $61.7M | $6.2M | $55.5M |
| Jun 2025 | $25.8M | $4.3M | $21.5M |
ADVNX Assets Under Management
Net assets of North Square Strategic Income Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $1.25B |
| 2026-02-28 | $1.07B |
| 2025-11-30 | $749.08M |
| 2025-08-31 | $584.10M |
| 2025-05-31 | $457.25M |
| 2025-04-30 | $395.96M |
| 2025-01-31 | $254.67M |
| 2024-10-31 | $217.33M |
| 2024-07-31 | $189.17M |
| 2024-04-30 | $164.64M |
| 2024-01-31 | $151.34M |
| 2023-10-31 | $142.84M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.